eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/12/2011
PIL Afinitor Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 12/09/2011 and displayed until 07/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 29/06/2011 and displayed until 12/09/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to side-effects
  • Change to MA holder contact details
  • Change to date of revision
Updated on 23/04/2010 and displayed until 29/06/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 18/11/2009 and displayed until 23/04/2010
Reasons for adding or updating:
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 21/09/2009 and displayed until 18/11/2009
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  everolimus